The Leukemia & Lymphoma Society cautions consumers to be wary of short-term plans and urges state and federal policymakers to protect patients.
A look at the implications for Medicaid plans.
Survey reveals stakeholders are taking a ‘wait-and-see’ attitude.
Healthcare executives rank the top 10 transformational themes for 2020.
Healthcare experts weigh in on what we can expect in 2019 and beyond.
The Trump Administration has taken a large interest in PBM drug rebates, which they say create higher drug prices. But do they?
What experts say will be the year’s biggest problems, and what can be done about them.
Four things you need to know about the Trump Administration’s proposed regs.
The much-anticipated 2018 midterm elections are over, but the effects on healthcare are lasting. What’s next?
As President Trump intensifies his battle with German Chancellor Angela Merkel over trade and NATO policies, he should pause to consider the lessons from another German Chancellor—Otto von Bismarck.